Q92733 (PRCC_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Proline-rich protein PRCC Alternative name(s): Papillary renal cell carcinoma translocation-associated gene protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 491 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May regulate cell cycle progression through interaction with MAD2L2. Ref.7 |
| Subunit structure | Interacts with MAD2L2; the interaction is direct. Ref.7 |
| Subcellular location | |
| Tissue specificity | Ubiquitous in fetal and adult tissues. |
| Involvement in disease | A chromosomal aberration involving PRCC is found in patients with papillary renal cell carcinoma. Translocation t(X;1)(p11.2;q21.2) with TFE3. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell cycle |
| Cellular component | Nucleus |
| Coding sequence diversity | Chromosomal rearrangement Polymorphism |
| Disease | Proto-oncogene |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | mitotic cell cycle checkpoint Inferred from direct assay Ref.7. Source: UniProtKB |
| Cellular_component | nucleus Inferred from direct assay Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 491 | 491 | Proline-rich protein PRCC | PRO_0000058568 | |||||
Regions | |||||||||
| Region | 1 – 100 | 100 | Mediates interaction with MAD2L2 | ||||||
| Compositional bias | 18 – 25 | 8 | Poly-Glu | ||||||
| Compositional bias | 52 – 55 | 4 | Poly-Pro | ||||||
| Compositional bias | 79 – 84 | 6 | Poly-Pro | ||||||
| Compositional bias | 91 – 94 | 4 | Poly-Pro | ||||||
| Compositional bias | 235 – 239 | 5 | Poly-Thr | ||||||
Amino acid modifications | |||||||||
| Modified residue | 97 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 114 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 157 | 1 | Phosphoserine Ref.9 Ref.11 Ref.13 | ||||||
| Modified residue | 159 | 1 | Phosphoserine Ref.9 Ref.11 Ref.13 | ||||||
| Modified residue | 212 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 218 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 239 | 1 | Phosphothreonine Ref.11 | ||||||
| Modified residue | 241 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 267 | 1 | Phosphoserine Ref.9 Ref.13 | ||||||
Natural variations | |||||||||
| Natural variant | 136 | 1 | P → S. Ref.3 Corresponds to variant rs11264542 [ dbSNP | Ensembl ]. | VAR_024341 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene." Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R., Ross M., Linehan W.M., Birdsall S., Shipley J., Cooper C.S. Hum. Mol. Genet. 5:1333-1338(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHROMOSOMAL TRANSLOCATION WITH TFE3. Tissue: Monocyte. |
| [2] | "Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas." Weterman M.A.J., Wilbrink M., Geurts van Kessel A. Proc. Natl. Acad. Sci. U.S.A. 93:15294-15298(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHROMOSOMAL TRANSLOCATION WITH TFE3. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT SER-136. Tissue: Caudate nucleus. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [7] | "Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas." Weterman M.A., van Groningen J.J., Tertoolen L., van Kessel A.G. Proc. Natl. Acad. Sci. U.S.A. 98:13808-13813(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MAD2L2, SUBCELLULAR LOCATION. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND SER-267, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [11] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; SER-114; SER-157; SER-159; SER-212; THR-239 AND SER-241, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND SER-267, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X97124 mRNA. Translation: CAA65791.1. X99720 Genomic DNA. Translation: CAA68060.1. AK289872 mRNA. Translation: BAF82561.1. AL590666 Genomic DNA. Translation: CAI16350.1. CH471121 Genomic DNA. Translation: EAW52909.1. BC004913 mRNA. Translation: AAH04913.1. |
| IPI | IPI00294618. |
| RefSeq | NP_005964.3. NM_005973.4. |
| UniGene | Hs.516948. |
3D structure databases | |
| ProteinModelPortal | Q92733. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q92733. 2 interactions. |
| MINT | MINT-4536336. |
| STRING | 9606.ENSP00000271526. |
PTM databases | |
| PhosphoSite | Q92733. |
Polymorphism databases | |
| DMDM | 2498802. |
Proteomic databases | |
| PaxDb | Q92733. |
| PRIDE | Q92733. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000271526; ENSP00000271526; ENSG00000143294. |
| GeneID | 5546. |
| KEGG | hsa:5546. |
| UCSC | uc001fqa.3. human. |
Organism-specific databases | |
| CTD | 5546. |
| GeneCards | GC01P156720. |
| HGNC | HGNC:9343. PRCC. |
| HPA | CAB017151. HPA019463. HPA019481. |
| MIM | 179755. gene. |
| neXtProt | NX_Q92733. |
| Orphanet | 319308. Translocation renal cell carcinoma. |
| PharmGKB | PA33704. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG283173. |
| HOGENOM | HOG000247067. |
| HOVERGEN | HBG002845. |
| InParanoid | Q92733. |
| KO | K13105. |
| OMA | PYAFSRK. |
| OrthoDB | EOG4MSCZR. |
| PhylomeDB | Q92733. |
Gene expression databases | |
| ArrayExpress | Q92733. |
| Bgee | Q92733. |
| CleanEx | HS_PRCC. |
| Genevestigator | Q92733. |
| GermOnline | ENSG00000143294. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018800. PRCC_C. [Graphical view] |
| Pfam | PF10253. PRCC_Cterm. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | PRCC. human. |
| GenomeRNAi | 5546. |
| NextBio | 21488. |
| SOURCE | Search... |
Entry information
| Entry name | PRCC_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92733 Secondary accession number(s): A8K1F7 Q5SZ06 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
